Glutamine Popsicles in Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00204958 |
Recruitment Status
:
Completed
First Posted
: September 20, 2005
Last Update Posted
: October 1, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Bone Marrow Transplantation Hematopoietic Stem Cell Transplantion | Drug: nutritional supplement Drug: glutamine popsicle | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 50 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | Double |
Primary Purpose: | Prevention |
Official Title: | Evaluation of Glutamine Popsicles in Adult/Pediatric Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients |
Study Start Date : | February 2004 |
Actual Primary Completion Date : | May 2007 |
Actual Study Completion Date : | May 2007 |

- grade of mucositis
- need for intravenous versus oral nutritional supplementation

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 4 Years to 75 Years (Child, Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Males
- Nonpregnant females
- Receiving chemotherapy for BMT/HSCT
Exclusion Criteria:
- Documented hepatic dysfunction
- History of cirrhosis
- History of acute renal failure (creatinine clearance < 25 mL/min)
- Gastrointestinal malabsorptive disorder

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00204958
United States, Wisconsin | |
University of Wisconsin | |
Madison, Wisconsin, United States, 53792 |
Principal Investigator: | Gordon S Sacks, PharmD., FCCP, BCNSP | University of Wisconsin, Madison |
Responsible Party: | University of Wisconsin, Madison |
ClinicalTrials.gov Identifier: | NCT00204958 History of Changes |
Other Study ID Numbers: |
2003-222 |
First Posted: | September 20, 2005 Key Record Dates |
Last Update Posted: | October 1, 2015 |
Last Verified: | September 2015 |
Keywords provided by University of Wisconsin, Madison:
bone marrow transplant (BMT) hematopoietic stem cell transplant (HSCT) |